Guidelines for mono, double and triple antithrombotic therapy
2021 ◽
pp. postgradmedj-2020-138938
Keyword(s):
Guidelines for antithrombotic therapy are complex, especially if a patient has several indications that require antithrombotic therapy. In general, no patient should receive lifelong double or triple antithrombotic therapy. In this overview, we outline the most common indications for mono, double and triple antithrombotic therapy; the preferred antithrombotic therapy and the recommended duration of therapy. Both antiplatelet therapy and therapeutic anticoagulation therapy with vitamin K antagonists or direct oral anticoagulants were included. European guidelines were used or, if no European guidelines were available, the Dutch guidelines were used.
2018 ◽
Vol 45
(02)
◽
pp. 205-214
◽
2021 ◽
Vol 77
(18)
◽
pp. 1727
2021 ◽
Vol 29
(1)
◽
2020 ◽
Vol 25
(4)
◽
pp. 316-323
Keyword(s):
2015 ◽
Vol 4
(1)
◽
pp. 44
◽